World

Covid can occasionally trigger rare Guillain-Barré syndrome

Covid can cause rare paralysis Guillain-Barré syndrome in rare cases, research claims

  • Guillain-Barré Syndrome can cause paralysis and cause severe pain in patients
  • One study suggests that this condition is rarely associated with Covid
  • The author says the virus can sometimes cause a debilitating condition


Studies claim that Covid can occasionally trigger Guillain-Barré syndrome (GBS).

Autoimmune disorders that can paralyze patients and leave them with severe pain, coronavirus Vaccine in very rare cases.

The coronavirus itself is not listed as a known trigger for the condition United Kingdom National Health Service, Even if it is named for other infectious diseases.

But patient research China, Denmark, France, Greece, Italy, the Netherlands, Spain, Switzerland, and the United Kingdom suggest a correlation between infection and condition.

The authors of the study emphasized that strong associations with GBS and Covid are unlikely.

However, a team at Rotterdam University argued that the virus could cause the condition in a small number of infected people.

It does not show any rate of how rare the post-covid condition is, but it is believed that only 1 in 10,000 people vaccinated with AstraZeneca is affected.

The study, published in the journal Brain, analyzed the profiles of 49 GBS patients who were overthrown between January and May last year.

In this condition, which can be caused by the flu or glandular fever, the immune system weakens and begins to attack nerve cells.

Studies claim that Covid can occasionally trigger Guillain-Barré syndrome (GBS).Photo: Three fathers, William Marsh, 57, remained paralyzed last year but are not believed to be one of the 22 patients who first suffered from Covid.

What is Guillain-Barré Syndrome?

Guillain-Barré syndrome is a rare condition in which the immune system becomes overdriven and the body attacks its own nerves.

Common symptoms of rare conditions include weakness in the limbs and tingling.

When a patient’s condition worsens, it can paralyze parts of the body and, in some cases, the entire body.

This syndrome is rare and affects about 1 in 100,000 people each year in the United Kingdom and the United States.

According to the National Institute of Neurological Disorders and Stroke, less than 20,000 cases are diagnosed annually in the United States.

According to doctors, it is often caused by viral or bacterial illnesses such as Campylobacter jejuni.

There is no cure. Treatment focuses on the recovery of the nervous system.

If it involves the respiratory muscles, it can be fatal.

Most people who suffer from this condition recover completely, but one in five may have long-term problems such as difficulty walking. In rare cases, it can be killed.

The study showed that 22% (11) of GBS patients were infected with the virus.

All of these patients were over 50 years of age and most suffered from facial nerve paralysis, or facial muscle weakness.

All patients met the diagnostic criteria for both Guillain-Barré syndrome and Covid.

However, the researchers said they did not find more GBS patients during the year compared to the previous year, despite the onset of the pandemic.

Dr. Bart Jacobs, a neurologist who is the lead author of the study, said:

But he added: “The existence of a true association or causality still needs to be established.”

After the EU health watchdog said that AstraZeneca’s Covid vaccine could cause GBS in “very rare” cases.

Earlier this month, the European Medicines Agency said 833 of the 592 million doses were reported worldwide.

We conclude that the overall risk of suffering from post-vaccination syndrome of British-made jabs is less than 1 in 10,000.

Experts emphasize that vaccination remains the best option, as the risk of serious illness and long-term complications from Covid infection is much higher.

The EMA said Guillain-Barré considers the side effects of Oxford jabs to be “at least a reasonable possibility.”

Regulators have already listed the status of Johnson & Johnson single-dose vaccines that use the same technology as AZ Jab.

There were 393 cases in the UK after the jab vaccination, but Watchdog is not convinced that this condition occurs more often than usual.

The European Medicines Agency today reported 833 Guillain-Barré syndromes worldwide out of 592 million doses.The overall risk of suffering from AstraZeneca's post-vaccination syndrome was found to be less than 1 in 10,000

The European Medicines Agency today reported 833 Guillain-Barré syndromes worldwide out of 592 million doses.The overall risk of suffering from AstraZeneca’s post-vaccination syndrome was found to be less than 1 in 10,000

The graph above shows the number of Guillain-Barré cases detected after the Covid vaccine was given in the United Kingdom. MHRA, a UK medical regulator, said it was unable to

The graph above shows the number of Guillain-Barré cases detected after the Covid vaccine was given in the United Kingdom. MHRA, a UK medical regulator, said it was unable to “confirm or exclude” a potential link between AstraZeneca’s jabs and their condition.

advertisement

Covid can occasionally trigger rare Guillain-Barré syndrome

Source link Covid can occasionally trigger rare Guillain-Barré syndrome

Back to top button